Oral Abstract Session: Islet transplantation: Novel therapies and novel methods
Sunday October 29, 2023 from 10:00 to 11:30
Indigo A
Moderators
Lectures
-
410.1 Perlecan: An islet basement membrane protein with anti-inflammatory qualitiesPaul R.V. Johnson, United Kingdom
-
410.2 Engineered pancreatic islets: Perinatal amnion epithelial cells in Support to pancreatic islet transplantationDr. Roberto Gramignoli, Sweden
-
410.3 Hyperoxygeneration of chloroplast in hydrogel composed of alginate-peptide conjugate for successful pancreatic islet transplantationMiss ChaeRim Yoo, Korea
-
410.4 Functional subcutaneous engraftment of human islets achieved by co-transplantation with vasculogenic and adaptable endothelial cellsDr. Ge Li, United States
-
410.5 Prolactin modulates the differentiation of pancreatic ductal cell to islet-like cellDr. Yi Wang, People's Republic of China
-
410.6 Gastrin-17 promotes survival and function and decreases inflammation of long-term cultured human isletsDr. Keiko Omori, United States
-
410.7 ILV-001 a highly promising therapeutic agent for islet transplantationDr. Karim Bouzakri, France
-
410.8 Improving the safety of stem-cell-derived beta cell transplantation with an inducible safety switchDr. Simon N Chu, United States
-
410.9 Expansion and Differentiation of Human Pancreas-derived Islet Cell Precursors into Functional Islet Cell OrganoidsDr. Bashoo Naziruddin, United States